Search
for
Sort by
Research 541–570 of 1000+
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Non-hemorrhage-related adverse effects of rivaroxaban
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Clinical Predictors of Outcome in Nonsegmental Vitiligo: A Prospective Cohort Study
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- To evaluate the outcome of combined therapy of cyproterone acetate and ethinyl estradiol in PCOS
- A Systematic Review of the Outcome of Hair Transplantation in Primary Scarring Alopecia
- Reporting on Adverse Clinical Events
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Effect of iron-deficiency anemia on the outcomes of pregnancy, labor, and newborn health
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- Reversible Anagen Effluvium Induced by Azathioprine: A Rare Adverse Effect Case Report
- Assessing the Environmental and Health Adverse Effects of Mercury Released From Dental Amalgam: A Literature Review
- A case of alopecia areata after rabies vaccination: unreported adverse effect?
- Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?
- A Novel Nomogram for Predicting Gonadotropin-Releasing Hormone Analogue Treatment Outcome in Girls with Idiopathic Central Precocious Puberty
- Patient-Centered Combination Therapies for Hair Restoration: Synergistic Mechanisms of Platelet-Rich Plasma and Microneedling, Personalized Approaches, and Evidence-Based Outcomes